Biocon Biologics in Covid-19 antibody deal; Byju's mopping up smaller rivals; th
Biocon Biologics, a fully integrated biosimilars company and a subsidiary of Biocon, has won an exclusive license from US-based Adagio Therapeutics to manufacture and commercialise an antibody treatme
Jul 27, 2021, 11:00 IST
More Podcasts
- Home /
- Podcast /
- Forbes-india-daily-tech-brief-podcast /
- Biocon-biologics-in-covid19-antibody-deal-byjus-mopping-up-smaller-rivals-the-promise-of-indias-saas-companies